SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zscaler, Inc. engages in the provision of a cloud-based internet security platform. It offers Zero Trust Exchange, Zscaler Client Connector, Zscaler Internet Access, Zscaler Private Access, Zscaler B2B, Zscaler Cloud Protection, and Zscaler Digital Experience. The company was founded by Jagtar Singh Chaudhry and K. Kailash in September 2007 and is headquartered in San Jose, CA.

Zscaler Inc

Zscalers Investor Day has fueled a rally as management reaffirmed its outlook and highlighted a long-term growth ambition, alongside an AI-security collaboration with IBM and Red Hat; analysts responded with multiple price-target hikes. Traders are broadly encouraged by the AI-security opportunity, though some question whether the long-term growth goals justify the valuation.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironments fiscal Q1 results beat expectations and showed a record funded backlog, reinforcing bullish interest in its drone and counter-drone businesses. The debate is whether those orders will translate into stronger growth and profitability: management maintained its full-year outlook, and some traders remain concerned about execution and the stocks muted, volatile reaction.

Fastly, Inc. provides real-time content delivery network services. It offers edge compute, edge delivery, edge security, edge applications like load balancing and image optimization, video on demand, and managed edge delivery. The company was founded by Artur Bergman, Tyler McMullen, Simon Wistow, and Gil Penchina in March 2011 and is headquartered in San Francisco, CA.

Fastly Inc - Ordinary Shares - Class A

Fastly Inc

Fastlys sharp rally is being tied to Oppenheimers upgrade, which cited rising contract values and early monetization of traffic from agentic AI applications. Traders are bullish on the AI-edge opportunity and discuss possible short covering, while others question how much revenue the AI traffic will generate and warn the stocks moves may be volatile.

Amplify Commodity Trust - Breakwave Tanker Shipping ETF

Breakwave Tanker Shipping ETF

Iran-related attacks and disruption around the Strait of Hormuz are keeping tanker availability tight and freight rates elevated, driving attention to BWETs tanker-futures exposure. Traders are split between viewing persistent shipping risks as supportive and warning that the funds steep run-up leaves it vulnerable to a sharp reversal if tensions ease or traffic normalizes.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Branded and ImprimisRx. The Branded segment includes activities of the company’s FDA approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain branded products. The ImprimisRx segment represents activities in the company’s ophthalmology-focused pharmaceutical compounding business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrows recent quarterly revenue shortfall and concerns about meeting its full-year outlook are driving discussion, particularly doubts about VEVYEs pricing and whether prescription growth is translating into revenue. Traders are split between skepticism over managements forecasting and execution and the view that the setback is temporary, with growth from VEVYE, IHEEZO and the broader ophthalmology portfolio supporting the longer-term thesis.

Robinhood GLD is a tokenized representation of SPDR Gold Shares (GLD) common stock, issued on Robinhood Chain, Robinhood's own blockchain built to bring tokenized real-world assets on-chain. Each token is designed to track the price of the underlying GLD share, giving holders on-chain price exposure to SPDR Gold Shares's stock. The token is freely transferable and composable across the Robinhood Chain ecosystem. It's part of Robinhood's broader initiative to expand access to tokenized U.S. equities via blockchain technology, alongside a wider lineup of tokenized stock tokens launching on the same network.

GoldCoin

Golds sharp pullback and rebound are driving discussion, with traders linking recent weakness to elevated Treasury yields, a stronger dollar and hawkish Fed-rate expectations. The community is split between looking for a technical bottom and expecting more downside, while some see easing dollar or yield pressure as support for a recovery.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

LINKs volatile rebound has traders watching for a breakout, while bullish holders point to Chainlinks role in institutional tokenization and crypto infrastructure. Others see the move as a short-lived pump, note its correlation with broader crypto markets, and question whether network adoption will translate into value for the LINK token.

GEOM maps the world's oil fields, mines, rare earths, and power plants, tracks what is and isn't tokenized, and cryptographically signs every dataset it publishes. Anyone can verify what we said and when. No account, no key, no permission. Sources include the WRI Global Power Plant Database and Global Energy Monitor (CC BY 4.0), attributed in full inside the app. Most of it already exists, spread across filings and terminals no one reads. GEOM gathers it and records where each figure came from.

GEOM

GEOM is drawing attention around traders thesis that its planned platform could tokenize oil and mineral assets and royalties, with the community linking its prospects to Greenland Energy (GLND), USFM and possible project partners; platform deployment and partner announcements are discussed as future catalysts, not confirmed outcomes. Bullish posts tout the concept, while others point to the tokens sharp swings, thin liquidity and uncertainty about execution, with some calling the selloff a potential rug pull.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is drawing attention amid a broad rally in Brazilian equities after Brazils first-round election results, which traders see as a potentially market-friendly political shift. The move has prompted bullish momentum and options chatter, alongside caution that gains may be driven by macro sentiment rather than company-specific news.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

SHIB is drawing attention for a modest price bounce within a prolonged consolidation, with traders watching resistance for signs of a breakout. Some expect renewed meme-coin momentum, while others remain frustrated by the tokens choppy, largely flat trading and doubt it can sustain a rally.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Brief Healthcare: PolyPeptide: Strategic Review Is Real, But the Setup Isn’t Clean and more

In this briefing: PolyPeptide: Strategic Review Is Real, But the Setup Isn’t Clean Aequitas: Integris Medtech Ltd Pre-IPO: Medtech Platform with Strong Growth but Elevated Leverage Tetratherix Limited - Commercialising the Platform Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Primer: Kopran Ltd (KOP IN) - Apr 2026 1. PolyPeptide: Strategic Review Is Real, But the Setup Isn’t Clean PolyPeptide is in a credible strategic review process, but at CHF37.25 the market already prices a 58.3% deal probability, leaving limited upside relative to downside risk in a break scenario. While a full re-rating implies valuation above CHF 50, sponsor return constraints anchor a realistic takeout in the low-to-mid 40s, supported by LBO analysis and peer multiple comparisons. The controlling shareholder structure introduces a third outcome where minorities may not receive a full premium, meaning “a deal” does not necessarily translate into immediate value crystallisation for investors. 2. Aequitas: Integris Medtech Ltd Pre-IPO: Medtech Platform with Strong Growth but Elevated Leverage Integris Medtech Limited (1234518D IN) (IML) plans to raise around US$340m in its upcoming IPO.

Brief Healthcare: Tetratherix Limited - Commercialising the Platform and more

In this briefing: Tetratherix Limited - Commercialising the Platform Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Primer: Kopran Ltd (KOP IN) - Apr 2026 Sirius (靖因生物) Pre-IPO: Pipeline Prioritization and Competitor Updates TransThera Placement (2617 HK): Tinengotinib Alone Can’t Signal Any Major Upheaval of Fortunes 1. Tetratherix Limited - Commercialising the Platform Tetratherix Limited (ASX:TTX) is an Australian biomedical company commercialising a proprietary polymer platform, Tetramatrix, across four franchises: bone regeneration, tissue spacing, tissue healing and precision medicine. Tetramatrix is a novel fully synthetic, water-based injectable polymer that transitions from a liquid to a solid matrix/scaffold when it enters the human body (at 37°C). As the product mimics natural tissue, it offers potential advantages versus existing animal-derived solutions that are prone to immune responses like inflammation. 2. Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Solara is a pure-play Active Pharmaceutical Ingredients (API) manufacturer emerging from a significant operational and financial reset, showing early signs of a turnaround with improved profitability and cash flows in the most recent fiscal year.

Brief Equities Bottom-Up: Primer: Arvind Fashions (ARVINDFA IN) - Apr 2026 and more

In this briefing: Primer: Arvind Fashions (ARVINDFA IN) - Apr 2026 Primer: Vedant Fashions (MANYAVAR IN) - Apr 2026 Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Primer: Sunwoda Electronic Co Ltd A (300207 CH) - Apr 2026 Primer: Kopran Ltd (KOP IN) - Apr 2026 1. Primer: Arvind Fashions (ARVINDFA IN) - Apr 2026 Arvind Fashions holds a strong position in India's apparel market through a focused portfolio of high-recognition, premium, and bridge-to-luxury brands, most notably the licensed brand U.S. Polo Assn., which is a significant revenue driver. The company is pursuing a clear growth strategy centered on expanding its retail footprint via an asset-light franchise model, enhancing its omnichannel capabilities, and growing its direct-to-consumer (D2C) business to improve margins and customer engagement. After a period of portfolio rationalization and financial volatility, the company has shown signs of a turnaround with improving profitability metrics and a strengthened balance sheet, although it faces intense competition and risks associated with licensed brand agreements.

Brief Growth Ideas: Aequitas: Rentmojo Ltd Pre-IPO Tearsheet and more

In this briefing: Aequitas: Rentmojo Ltd Pre-IPO Tearsheet Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Primer: Sunwoda Electronic Co Ltd A (300207 CH) - Apr 2026 Primer: Kopran Ltd (KOP IN) - Apr 2026 X-Energy Inc. (XE): Amazon Backed Advanced Nuclear Reactor Tech Company Sets Terms for IPO 1. Aequitas: Rentmojo Ltd Pre-IPO Tearsheet Rentmojo Ltd (RMJL IN) s looking to raise about US$126m in its upcoming India IPO. The deal will be run by Axis, IIFL and Motilal Oswal. Rentmojo operates a technology-driven, full-stack direct-to-consumer online rental and subscription platform for furniture and appliances in India, spanning across category management, designing, procurement, refurbishment, servicing, reverse logistics and multi-cycle redeployment. According to Redseer, it was the largest home furniture and appliances online rental and subscription platform(based on live subscribers) as of FY25 and Sep 30, 2025, and subscription revenue(during FY25). 2. Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Solara is a pure-play Active Pharmaceutical Ingredients (API) manufacturer emerging from a significant operational and financial reset, showing early signs of a turnaround with improved profitability and cash flows in the most recent fiscal year.

Brief India: Aequitas: Rentmojo Ltd Pre-IPO Tearsheet and more

In this briefing: Aequitas: Rentmojo Ltd Pre-IPO Tearsheet Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Primer: Kopran Ltd (KOP IN) - Apr 2026 Primer: Home First Finance (HOMEFIRS IN) - Apr 2026 HSIE Results Daily: ICICI Prudential Life Insurance Company 1. Aequitas: Rentmojo Ltd Pre-IPO Tearsheet Rentmojo Ltd (RMJL IN) s looking to raise about US$126m in its upcoming India IPO. The deal will be run by Axis, IIFL and Motilal Oswal. Rentmojo operates a technology-driven, full-stack direct-to-consumer online rental and subscription platform for furniture and appliances in India, spanning across category management, designing, procurement, refurbishment, servicing, reverse logistics and multi-cycle redeployment. According to Redseer, it was the largest home furniture and appliances online rental and subscription platform(based on live subscribers) as of FY25 and Sep 30, 2025, and subscription revenue(during FY25). 2. Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Solara is a pure-play Active Pharmaceutical Ingredients (API) manufacturer emerging from a significant operational and financial reset, showing early signs of a turnaround with improved profitability and cash flows in the most recent fiscal year.

Brief Equities Bottom-Up: Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 and more

In this briefing: Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Primer: Sunwoda Electronic Co Ltd A (300207 CH) - Apr 2026 Primer: Kopran Ltd (KOP IN) - Apr 2026 Sony Financial Group (8729) - Cheap Vs Peers and Growing Out of Its ROE Hole Primer: Aspial Corp Ltd (ASP SP) - Apr 2026 1. Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Solara is a pure-play Active Pharmaceutical Ingredients (API) manufacturer emerging from a significant operational and financial reset, showing early signs of a turnaround with improved profitability and cash flows in the most recent fiscal year. The company holds a strong position in several key products, including being a global leader in Ibuprofen, and benefits from a strong regulatory track record with approvals from major authorities like the US FDA and EDQM, which is critical for serving highly regulated markets. High operational gearing, significant historical earnings volatility, and intense competition in the generic API space present considerable risks, but the company's strategic shift towards higher-value products and improving financial health offer potential upside.

Brief India: Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 and more

In this briefing: Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Primer: Kopran Ltd (KOP IN) - Apr 2026 Primer: Home First Finance (HOMEFIRS IN) - Apr 2026 HSIE Results Daily: ICICI Prudential Life Insurance Company Pharmaceuticals: IPM: 11% growth in Mar-26, 10% in FY26 1. Primer: Solara Active Pharma Sciences (SOLARA IN) - Apr 2026 Solara is a pure-play Active Pharmaceutical Ingredients (API) manufacturer emerging from a significant operational and financial reset, showing early signs of a turnaround with improved profitability and cash flows in the most recent fiscal year. The company holds a strong position in several key products, including being a global leader in Ibuprofen, and benefits from a strong regulatory track record with approvals from major authorities like the US FDA and EDQM, which is critical for serving highly regulated markets. High operational gearing, significant historical earnings volatility, and intense competition in the generic API space present considerable risks, but the company's strategic shift towards higher-value products and improving financial health offer potential upside.

Brief Growth Ideas: Primer: Sunwoda Electronic Co Ltd A (300207 CH) - Apr 2026 and more

In this briefing: Primer: Sunwoda Electronic Co Ltd A (300207 CH) - Apr 2026 Primer: Kopran Ltd (KOP IN) - Apr 2026 X-Energy Inc. (XE): Amazon Backed Advanced Nuclear Reactor Tech Company Sets Terms for IPO Sony Financial Group (8729) - Cheap Vs Peers and Growing Out of Its ROE Hole Sirius (靖因生物) Pre-IPO: Pipeline Prioritization and Competitor Updates 1. Primer: Sunwoda Electronic Co Ltd A (300207 CH) - Apr 2026 Sunwoda is a global leader in lithium-ion batteries, with diversified exposure across consumer electronics (3C), electric vehicles (EV), and energy storage systems (ESS), positioning it to capitalize on broad-based electrification trends. The company exhibits a strong growth trajectory, evidenced by a 3-year revenue CAGR of 14.52% and net income CAGR of 17.05%. However, this growth is capital-intensive, resulting in consistently negative free cash flow and a lower resilience score. Strategic expansion into high-growth EV and ESS markets complements its established leadership in 3C batteries, but the company faces intense competition, margin pressure, and significant operational risks, including supply chain volatility and customer quality disputes.

Brief Equities Bottom-Up: Primer: Kopran Ltd (KOP IN) - Apr 2026 and more

In this briefing: Primer: Kopran Ltd (KOP IN) - Apr 2026 Sony Financial Group (8729) - Cheap Vs Peers and Growing Out of Its ROE Hole Primer: Aspial Corp Ltd (ASP SP) - Apr 2026 Primer: Aspial Lifestyle (ASPL SP) - Apr 2026 Primer: Home First Finance (HOMEFIRS IN) - Apr 2026 1. Primer: Kopran Ltd (KOP IN) - Apr 2026 Kopran is an established, integrated pharmaceutical company with a dual focus on Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDF), leveraging over 60 years of experience. The company has a strong global presence, exporting to over 60 countries. The company's financial performance shows consistent long-term revenue growth, but has been marred by recent margin pressure and a significant decline in 3-year net income and EPS. Negative free cash flow, driven by capital expenditures for capacity expansion, is a key concern. Strategically, Kopran is focused on expanding its API capacity, developing niche products, and reducing its reliance on Chinese raw materials.

Brief Growth Ideas: Primer: Kopran Ltd (KOP IN) - Apr 2026 and more

In this briefing: Primer: Kopran Ltd (KOP IN) - Apr 2026 X-Energy Inc. (XE): Amazon Backed Advanced Nuclear Reactor Tech Company Sets Terms for IPO Sony Financial Group (8729) - Cheap Vs Peers and Growing Out of Its ROE Hole Sirius (靖因生物) Pre-IPO: Pipeline Prioritization and Competitor Updates Primer: Aspial Corp Ltd (ASP SP) - Apr 2026 1. Primer: Kopran Ltd (KOP IN) - Apr 2026 Kopran is an established, integrated pharmaceutical company with a dual focus on Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDF), leveraging over 60 years of experience. The company has a strong global presence, exporting to over 60 countries. The company's financial performance shows consistent long-term revenue growth, but has been marred by recent margin pressure and a significant decline in 3-year net income and EPS. Negative free cash flow, driven by capital expenditures for capacity expansion, is a key concern. Strategically, Kopran is focused on expanding its API capacity, developing niche products, and reducing its reliance on Chinese raw materials.

Kopran Ltd. is a holding company, which engages in the manufacturing of pharmaceuticals and related products. It operates through the following business units: Formulations, and Active Pharmaceutical Ingredients. The firm's products include Amyn, Lokit, and Ciproquin. The company was founded on April 26, 1958 and is headquartered in Mumbai, India.

Feed

News

Sentiment

Fundamentals

Info

KOPRAN.NSE Kopran Ltd.

Latest KOPRAN.NSE News